West Pharma (WST) Reports Q3 EPS of $0.44
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
West Announces Third Quarter 2015 Results
October 29, 2015 7:01 AM EDTEXTON, PA -- (Marketwired) -- 10/29/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2015 and updated financial guidance for the full year 2015.
Executive Summary
Third quarter 2015 reported sales of $344.5 million were 3.2% below prior-year sales. Net sales at constant currency grew by 5.2% as foreign currency translation reduced reported sales by over 8%. Gross margin improves year-over-year on growth in high-value pharmaceutical packaging sales. Third quarter reported diluted EPS was $0.02. Adjusted diluted EPS of $0.44 excludes a $0.42 non-cash pension-settlement charge. EPS comparisons to the... More